loadpatents
Patent applications and USPTO patent grants for CHU de Nantes.The latest application filed is for "combination therapy for treating adult patients with relapsed/refractory cd22+ b-cell acute lymphoblastic leukemia".
Patent | Date |
---|---|
Combination Therapy For Treating Adult Patients With Relapsed/refractory Cd22+ B-cell Acute Lymphoblastic Leukemia App 20160304611 - Chevallier; Patrice ;   et al. | 2016-10-20 |
Y-90-labeled Anti-cd22 Antibody (epratuzumab Tetraxetan) In Refractory/relapsed Adult Cd22+ B-cell Acute Lymphoblastic Leukemia App 20160296648 - Chevallier; Patrice ;   et al. | 2016-10-13 |
Novel Alternative Splice Transcripts For Mhc Class I Related Chain Alpha (mica) And Uses Thereof App 20160176943 - CHARREAU; Beatrice ;   et al. | 2016-06-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.